EVOKE PHARMA, INC. Amended Reports
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2024-05-14: Form 10-K/A; Period of report 2023-12-31; Description 10-K/A; Document evok-20231231.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2024-05-14 | 10-K/A | 2023-12-31 | 10-K/A | evok-20231231.htm |